SCHEMBL7658317

SCHEMBL7658317

CCOC(=O)/C=C/CCc1cc(Cl)cc2[nH]c(C(=O)OC)cc12

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 13/20 0.41
ULK1 O75385 1/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7658321 1.00 ALOX15 (0.41) ALOX15ULK1MAPT
SCHEMBL7550281 0.87 ULK1 (0.35) ALOX15ULK1
SCHEMBL7550279 0.87 ULK1 (0.35) ALOX15ULK1
SCHEMBL7547455 0.82 ULK1 (0.41) ALOX15ULK1
SCHEMBL7653241 0.79 ALOX15 (0.36) ALOX15MAPT
SCHEMBL7653239 0.79 ALOX15 (0.36) ALOX15MAPT
SCHEMBL7550428 0.76 ULK1 (0.41) ALOX15ULK1
SCHEMBL9433015 0.70 GRIN1 (0.66) ALOX15ULK1
SCHEMBL30695188 0.69 ALOX15 (0.62) ALOX15MAPT
SCHEMBL1093057 0.69 ALOX15 (0.62) ALOX15MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6495587-B1 TREATING A DAMAGE TO THE CENTRAL NERVOUS SYSTEM INDUCED BY AN ISCHEMIC OR HYPOXIC CONDITION AND STROKE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2002-12-17 US disclosed
EP-1163220-A1 TRICYCLIC INDOLE-2-CARBOXYLIC ACID COMPOUND USED AS NMDA RECEPTOR ANTAGONIST SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-12-19 EP disclosed
WO-2000056711-A1 TRICYCLIC INDOLE-2-CARBOXYLIC ACID COMPOUND USED AS NMDA RECEPTOR ANTAGONIST SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2000-09-28 WO disclosed